EMPACT-MI Trademark

Trademark Overview

On Friday, August 28, 2020, a trademark application was filed for EMPACT-MI with the United States Patent and Trademark Office. The USPTO has given the EMPACT-MI trademark a serial number of 79296363. The federal status of this trademark filing is REGISTERED as of Tuesday, May 25, 2021. This trademark is owned by Boehringer Ingelheim International GmbH. The EMPACT-MI trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research in the field of diabetes and cardiovascular diseases; providing medical and scientific research information in the field of diabetes and cardiovascular diseases
empact-mi

General Information

Serial Number79296363
Word MarkEMPACT-MI
Filing DateFriday, August 28, 2020
Status700 - REGISTERED
Status DateTuesday, May 25, 2021
Registration Number6358608
Registration DateTuesday, May 25, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 9, 2021

Trademark Statements

Goods and ServicesMedical and scientific research in the field of diabetes and cardiovascular diseases; providing medical and scientific research information in the field of diabetes and cardiovascular diseases
Translation of Words in MarkThe wording "EMPACT-MI" has no meaning in a foreign language.

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, October 26, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBoehringer Ingelheim International GmbH
Party Type30 - Original Registrant
Legal Entity Type27 - NOT AVAILABLE
AddressDE
Party NameBoehringer Ingelheim International GmbH
Party Type20 - Owner at Publication
Legal Entity Type27 - NOT AVAILABLE
AddressDE
Party NameBoehringer Ingelheim International GmbH
Party Type10 - Original Applicant
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Trademark Events

Event DateEvent Description
Friday, October 22, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 22, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, October 22, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 22, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 4, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, September 16, 2021FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, September 15, 2021FINAL DISPOSITION PROCESSED
Wednesday, August 25, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, May 25, 2021REGISTERED-PRINCIPAL REGISTER
Monday, March 15, 2021NOTIFICATION PROCESSED BY IB
Tuesday, March 9, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 9, 2021PUBLISHED FOR OPPOSITION
Wednesday, February 24, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 24, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 17, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, February 14, 2021REFUSAL PROCESSED BY IB
Friday, January 29, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 26, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 26, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 26, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 22, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, January 21, 2021REFUSAL PROCESSED BY MPU
Friday, January 1, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, December 31, 2020NON-FINAL ACTION WRITTEN
Wednesday, December 30, 2020ASSIGNED TO EXAMINER
Friday, October 30, 2020APPLICATION FILING RECEIPT MAILED
Monday, October 26, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, October 22, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

empact cardiovascular diseases medical diabetes field scientific research information providing